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Commentary 
Dr. Carias de Oliveira and colleagues performed an 
elegant evaluation of intermittent warm blood cardiople- 
gia and found that 15 minutes of cardioplegic nterruption 
with 15 minutes of reperfusion was well tolerated by the 
normal canine heart. They also found that 30 minutes of 
cardioplegic nterruption with 15 minutes of reperfusion 
resulted in substantial metabolic and functional deterio- 
ration that persisted at least 2 hours after cardioplegic 
arrest. They recommend that cardiac surgeons hould 
limit warm cardioplegic interruptions, particularly in pa- 
tients with poor preoperative l ft ventricular function, 
preoperative ischemia, or left ventricular hypertrophy. 
This is an excellent study, which deserves careful con- 
sideration by cardiac surgeons interested inwarm cardio- 
plegia. The authors used magnetic resonance spectros- 
copy (MRS) to assess myocardial pH and high-energy 
phosphates during intermittent warm cardioplegia nd 
reperfusion. MRS is a revolutionary assessment tool that 
allows noninvasive quantification of tissue metabolites in
vivo.I However, a number of cautions must be exercised in 
the interpretation f the results of this study. The authors 
used blood-perfused isolated canine hearts. The tolerance 
of normal canine myocardium to interrupted cardioplegia 
may differ, as the authors suggest, from that of a heart 
with coronary disease and preoperative ischemia. In this 
study, an intraventricular balloon was used to assess 
ventricular function. The authors found a significant in- 
crease in left ventricular end-diastolic pressure and a 
decrease in diastolic function after cardioplegic nterrup- 
tions of 20 or 30 minutes, This alteration in diastolic 
compliance renders the assessment of systolic function 
difficult. They found a decrease in end-systolic elastance 
after 30 minutes of cardioplegic interruption. Maximal 
elastance was not measured. A better measure of cardiac 
function would have been preload recruitable stroke 
work, which could have been calculated from pressure- 
volume loops. Unfortunately, the authors did not assess 
this measure of cardiac function. 
Their evaluation of cardiac high-energy phosphates and 
myocardial cidosis provides clear evidence of progressive 
ischemia during cardioplegic nterruptions. These results 
suggest cardiac surgeons hould limit warm cardioplegic 
interruptions to less than 30 minutes. Altering the method 
of delivering cardioplegic solutions may decrease car- 
dioplegic interruption times. In our experience, optimal 
visualization of distal anastomoses required interruption 
of warm antegrade cardioplegia for 10 to 20 minutes in 
90% of patients, corresponding to 42% of the crossclamp 
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period) The use of warm retrograde blood cardioplegia, in
Contrast, decreased cardioplegic nterruptions toonly 27% of 
the duration of crossclamping. This does not necessarily 
mean, however, that retrograde cardioplegia results in less 
ischemia. Retrograde cardioplegia may decrease cardiople- 
gic interruption time simply by decreasing tissue perfusion, 
which in turn leads to decreased effluent from coronary 
arteriotomies and improved visualization of the anastomosis. 
Indeed, retrograde cardioplegia results in increased levels of 
inorganic phosphate and decreased levels of creatine phos- 
phate compared with antegrade cardioplegia. 3 Using a com- 
bination of antegrade and retrograde cardioplegia (i.e., simul- 
taneous cardioplegia administration retrograde through the 
coronary sinus and antegrade through saphenous vein grafts) 
may be the optimal method of reducing the duration of 
cardioplegic nterruption without significantly impairing vis- 
ibility. 4 In addition, lowering the temperature of the car- 
dioplegic solution from 37 ° C to 29 ° C ("tepid" cardioplegia) 
may reduce myocardial oxygen requirements and improve 
the preservation of myocardial metabolism and ventricular 
function. 4 These Strategies may minimize the deleterious 
effects of cardioplegic nterruption during cardiac surgery. 
We have used arterial and coronary Sinus serum samples 
to evaluate myocardial metabolism during cardioplegic de- 
livery. We measured lactate production after resumption of 
antegrade or retrograde cardioplegia fter interruptions of 
up to 15 minutes (unpublished ata). Interruption of ante- 
grade warm blood cardioplegia results in moderate lactate 
washout with resumption of cardioplegia; the magnitude of 
this lactate production is not related to the duration of 
cardioplegic nterruption. In contrast, interruption of retro- 
grade warm blood cardioplegia results in greater lactate 
production at all times, compared with antegrade cardiople- 
gia, and lactate production and oxygen consumption i crease 
significantly after only 7 minutes (implying washout of lac- 
tate accumulated during anaerobic metabolism, and repay- 
ment of an oxygen debt). 
In addition to metabolic measurements, we have also 
assessed clinical outcomes during warm blood cardiople- 
gia. A randomized clinical trial comparing normothermic 
and hypothermic blood cardioplegia was performed in 
1732 patients at the University of Toronto. 5 It demon- 
strated a significant reduction in the incidence of low 
cardiac output syndrome and perioperative nzymatic 
myocardial infarction in patients randomized to warm 
blood cardioplegia. The effects of cardioplegic interrup- 
tion was subsequently assessed post hoc in 720 patients 
derived from the warm treatment arm. 6 Intermittency was 
analyzed as cumulative ischemic time as a percentage of 
total crossclamp time, or as the single longest ischemic 
interval. Longest ischemic time (highest quartile > 13 
minutes) was an important predictor of adverse cardiac 
outcomes (mortality, myocardial infarction, or low output 
syndrome, p = 0.053), but no consistent relationship was 
identified for cumulative ischemic time. We concluded 
that repeated interruptions of warm blood cardioplegia 
followed by sufficient cardioplegic reinfusion is a safe 
method of myocardial protection provided single inter- 
ruptions ar e 13 minutes or less. Dr. Carias de Oliveira and 
colleagues used a model of ischemia with 15 minutes of 
reperfusion between each ischemic episode. Although the 
length Of interruptions i compatible with clinical practice 
(average longest ischemic interval 11.4 -+ 4.0 mimites for 
732 patients from the Warm Heart Trial), 6 15 minutes of 
reperfusion may represent an ideal rather than reflect 
routine practice. Additional studies testing shorter peri- 
ods of reperfusion would provide valuable information 
that may more closely mimic typical surgeon behavior. It 
would appear from closer inspection of the first panel of 
Fig. 2, in conjunction with other animal data, 7that shorter 
periods of reperfusion would also be acceptable. 
In summary, this is a well-designed study assessing the 
effects of warm intermittent blood cardioplegia. The 
results uggest that 15 minutes of repeated warm ischemia 
is safe, but that cardioplegic interruptions of 30 minutes 
are probably harmful. This length of time is clinically 
feasible in the majority of coronary bypass operations, 
particularly if combinations of antegrade and retrograde 
cardloplegia re used. Our myocardial metabolic and 
clinical data would also suggest hat this length of warm 
ischemic time is well tolerated in coronary bypass urgery. 
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